New EU Market Hopefuls Await Their Fate; EMA Re-Adopting Zynteglo Opinion
Sponsors of a raft of new products will find out this week if the European Medicines Agency’s medicines evaluation committee, the CHMP, is convinced the therapies are ready for marketing.